β-blocker therapy in patients with heart failure in the urban setting: Moving beyond clinical trials

American Heart Journal

Volumn 148, Issue 6, 2004, Pages 958-963

  Estep, Jerry D ^a   Mehta, Sameer K ^a,b,c   Uddin, Fatema ^d   King, Louise ^d   Toto, Kathleen H ^c   Nelson, Lauren L ^c   Dries, Daniel L ^a,b   Yancy, Clyde W ^a   Drazner, Mark H ^a,b,c  

^a Heart Failure Research Unit   (United States)

^b Donald W Reynolds Cardiovascular Clinical Research Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIURETIC AGENT; METOPROLOL;

ADULT; AGED; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CARDIOLOGY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SPECIALIST; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URBAN AREA;

ADRENERGIC BETA-ANTAGONISTS; BLOOD PRESSURE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 10644220201     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.05.044     Document Type: Article

References (28)

1. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. Circulation. 104:2001;2996-3007
2. Bozkurt B., Agoston I., Knowlton A.A. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 41:2003;211-214
3. Cleland J.G., Cohen-Solal A., Aguilar J.C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 360:2002;1631-1639
4. Califf R.M., O'Connor C.M. Beta-blocker therapy for heart failure: the evidence is in, now the work begins. JAMA. 283:2000;1335-1337
5. Pinski S.L. Continuing progress in the treatment of severe congestive heart failure. JAMA. 289:2003;754-756
6. Fuat A., Hungin A.P., Murphy J.J. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 326:2003;196
7. McKee S.P., Leslie S.J., LeMaitre J.P., et al. Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail. 5:2003;549-555
8. Mehta S.K., Toto K.H., Nelson L.L., et al. Therapy of heart failure in African Americans: lessons from an urban public hospital. Congest Heart Fail. 10:2004;40-43
9. Neily J.B., Toto K.H., Gardner E.B., et al. Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. Am Heart J. 143:2002;29-33
10. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 142:2001;714-719
11. O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 13:1994;S107-112
12. Ansari M., Shlipak M.G., Heidenreich P.A., et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 107:2003;2799-2804
13. Ayanian J.Z. Generalists and specialists caring for patients with heart disease: united we stand, divided we fall. Am J Med. 108:2000;259-261
14. Massie B.M., Ansari M.N. Specialty care for heart failure: does it improve outcomes? Am Heart J. 145:2003;209-213
15. McMurray J., Cohen-Solal A., Dietz R., et al. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail. 3:2001;495-502
16. Metra M., Nodari S., Parrinello G., et al. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J. 145:2003;292-299
17. Eichhorn E.J., Heesch C.M., Risser R.C., et al. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol. 25:1995;154-162
18. Anthonio R.L., van Veldhuisen D.J., Breekland A., et al. Beta-blocker titration failure is independent of severity of heart failure. Am J Cardiol. 85:2000;509-512., A11
19. Macdonald P.S., Keogh A.M., Aboyoun C.L., et al. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure. J Am Coll Cardiol. 33:1999;924-931
20. Krum H., Ninio D., MacDonald P. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart. 84:2000;615-619
21. Maggioni A.P., Sinagra G., Opasich C., et al. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart. 89:2003;299-305
22. Butler J., Khadim G., Belue R., et al. Tolerability to beta-blocker therapy among heart failure patients in clinical practice. J Card Fail. 9:2003;203-209
23. Rouleau J.L., Roecker E.B., Tendera M., et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the COPERNICUS study. J Am Coll Cardiol. 43:2004;1423-1429
24. Schleman K.A., Lindenfeld J.A., Lowes B.D., et al. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. J Card Fail. 7:2001;4-12
25. Gupta R., Tang W.H., Young J.B. Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. Am Heart J. 147:2004;79-83
26. Krumholz H.M., Baker D.W., Ashton C.M., et al. Evaluating quality of care for patients with heart failure. Circulation. 101:2000;E122-140
27. Burns R., Nichols L.O., Graney M.J., et al. Mortality in a public and a private hospital compared: the severity of antecedent disorders in Medicare patients. Am J Public Health. 83:1993;966-971
28. Sin D.D., McAlister F.A. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med. 113:2002;650-656